Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia - PubMed (original) (raw)
Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia
G Zuliani et al. J Psychiatr Res. 2007 Oct.
Abstract
Some cytokines have been involved in the pathogenesis of late onset Alzheimer's disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-alpha, IL-1beta, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: *IL-1beta was higher in VD, LOAD, and CDND compared with controls (p<0.005). *TNF-alpha was higher in VD and LOAD compared to C (p<0.05), and in VD compared to LOAD (p<0.03). *IL-6 was higher in VD compared with LOAD (p<0.03). No differences in IL-10 values were found (Kruskal-Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1beta and TNF-alpha, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1beta and TNF-alpha levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.
Similar articles
- High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia.
Zuliani G, Guerra G, Ranzini M, Rossi L, Munari MR, Zurlo A, Blè A, Volpato S, Atti AR, Fellin R. Zuliani G, et al. Int J Geriatr Psychiatry. 2007 Apr;22(4):305-11. doi: 10.1002/gps.1674. Int J Geriatr Psychiatry. 2007. PMID: 17022108 - Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia.
Zuliani G, Cavalieri M, Galvani M, Passaro A, Munari MR, Bosi C, Zurlo A, Fellin R. Zuliani G, et al. J Neurol Sci. 2008 Sep 15;272(1-2):164-70. doi: 10.1016/j.jns.2008.05.020. Epub 2008 Jul 2. J Neurol Sci. 2008. PMID: 18597785 - Cytokines in Alzheimer's disease and vascular dementia.
Angelopoulos P, Agouridaki H, Vaiopoulos H, Siskou E, Doutsou K, Costa V, Baloyiannis SI. Angelopoulos P, et al. Int J Neurosci. 2008 Dec;118(12):1659-72. doi: 10.1080/00207450701392068. Int J Neurosci. 2008. PMID: 18937113 - [Relationships between weight loss and circulating cytokines in patients with Alzheimer's disease].
Mahieux F, Couderc R, Fénelon G, Maachi M. Mahieux F, et al. Psychol Neuropsychiatr Vieil. 2006 Dec;4(4):281-6. Psychol Neuropsychiatr Vieil. 2006. PMID: 17194648 Review. French. - Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations.
Bruunsgaard H. Bruunsgaard H. Eur Cytokine Netw. 2002 Oct-Dec;13(4):389-91. Eur Cytokine Netw. 2002. PMID: 12517724 Review.
Cited by
- Abnormal resting-state functional connectivity of hippocampal subregions in type 2 diabetes mellitus-associated cognitive decline.
Yao L, Li MY, Wang KC, Liu YZ, Zheng HZ, Zhong Z, Ma SQ, Yang HM, Sun MM, He M, Huang HP, Wang HF. Yao L, et al. Front Psychiatry. 2024 Sep 23;15:1360623. doi: 10.3389/fpsyt.2024.1360623. eCollection 2024. Front Psychiatry. 2024. PMID: 39376966 Free PMC article. - The Neglected Sibling: NLRP2 Inflammasome in the Nervous System.
Ducza L, Gaál B. Ducza L, et al. Aging Dis. 2024 May 7;15(3):1006-1028. doi: 10.14336/AD.2023.0926-1. Aging Dis. 2024. PMID: 38722788 Free PMC article. Review. - Metformin, Cognitive Function, and Changes in the Gut Microbiome.
Rosell-Díaz M, Fernández-Real JM. Rosell-Díaz M, et al. Endocr Rev. 2024 Mar 4;45(2):210-226. doi: 10.1210/endrev/bnad029. Endocr Rev. 2024. PMID: 37603460 Free PMC article. Review. - Emerging trends in IRAK-4 kinase research.
Yadav H, Shirumalla RK. Yadav H, et al. Mol Biol Rep. 2023 Sep;50(9):7825-7837. doi: 10.1007/s11033-023-08438-w. Epub 2023 Jul 25. Mol Biol Rep. 2023. PMID: 37490192 Review. - Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment.
Rajeev V, Chai YL, Poh L, Selvaraji S, Fann DY, Jo DG, De Silva TM, Drummond GR, Sobey CG, Arumugam TV, Chen CP, Lai MKP. Rajeev V, et al. Acta Neuropathol Commun. 2023 Jun 12;11(1):93. doi: 10.1186/s40478-023-01590-1. Acta Neuropathol Commun. 2023. PMID: 37309012 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical